Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Sum of short-term and long-term debt obligations
3Y CAGR
+14.1%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
1.5x
Solid growth
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $8.24M | -9.2% |
| 2023 | $9.08M | -14.1% |
| 2022 | $10.56M | +90.2% |
| 2021 | $5.55M | - |